On ECHEMI
Home > Drugs > Hepatic artery occlusion
Hepatic artery occlusion
Due to the dual blood supply to the liver, hepatic infarction caused by hepatic artery occlusion is rare. Hepatic artery occlusion can be caused by atherosclerosis, embolism, thrombosis, vasculitis or hypotensive shock. Occasionally, hepatic artery thrombosis can also occur during pregnancy or after oral contraceptives. This disease develops rapidly and is dangerous. Unless diagnosed and treated early, the mortality rate is high.
  • Site of disease:

    Liver blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    Middle-aged and elderly people
  • Related symptoms:

    Stomach ache liver congestion fever oliguria stomach ache
  • Concurrent disease:

Related Drugs
Dipyridamole dispersible tablets
Indication: For the prevention of thromboembolic disease.
Manufacturer:

Beijing Juneng Pharmaceutical Co., Ltd.

Dipyridamole sustained-release capsules
Indication: Prevention and treatment of thromboembolic disease, alone or in combination with aspirin.
Manufacturer:

NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

Xanthinol Nicotinate Tablets
Indication: Used for ischemic cerebrovascular disease and its sequelae; also used for thromboangiitis obliterans, phlebitis, etc.
Manufacturer:

Shanxi JINXIN DOUBLE-CRANE Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.